Stock ETNB 89BIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart 89bio, Inc.

Equities

ETNB

US2825591033

Market Closed - Nasdaq
Other stock markets
 21:00:00 14/05/2024 BST 		5-day change 1st Jan Change
9.09 USD +4.48% Intraday chart for 89bio, Inc. -2.99% -18.62%
05-14 89Bio Initiates Phase 3 Enlighten-Cirrhosis Trial of Pegozafermin in Metabolic Dysfunction-Associated Steatohepatitis Patients with Compensated Cirrhosis CI
05-10 HC Wainwright Adjusts 89bio's Price Target to $29 From $31, Maintains Buy Rating MT
9ae875cc8ce768c00c4c506b0148cd._cVPa3cxu5Vik-kTiV78mRyOhebuBp4WLnscJPE2ayQ.j6x_EgJA8MU16YZ44hvM4Fj-6p60QswvVjkxV5JTJnS5ox8pDQXp0RT2vA~01e3ddf6b0949eea77bcf8c4b792f21d
  1. Stock Market
  2. Equities
  3. ETNB Stock
  4. Charts 89bio, Inc.
  5. News Chart